We identified four main facial concerns that accompany GLP-1 treatments: accelerated volume loss and sagging, density loss, dehydration and wrinkles, Ronert said
Proc Natl Acad Sci USA 101 , 77117715, (2004)
The Aesthetic Opportunity in Weight Loss Treatments For med spa owners, the integration of weight loss medications creates a natural pathway to additional aesthetic services
February 3, 2026: Man Sues Ozempic, Claims the Injectable Semaglutide Caused Him to Lose Sight A man from Ohio has filed a legal claim against Ozempics manufacturer, Novo Nordisk, alleging that he developed NAION after taking Ozempic as prescribed
This cost advantage creates room for investment in clinical validation and consumer education, thereby supporting a premium-product claim backed by acetylation science